MetaADEDB 2.0 @ LMMD
Fondaparinux
(XEKSTYNIJLDDAZ-JASSWCPGSA-D)
Structure
SMILES
CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@H]([C@@H]([C@H]1NS(=O)(=O)[O-])O)O[C@@H]1O[C@@H](C(=O)[O-])[C@H]([C@@H]([C@H]1OS(=O)(=O)[O-])O)O[C@H]1O[C@H](COS(=O)(=O)[O-])[C@H]([C@@H]([C@H]1NS(=O)(=O)[O-])OS(=O)(=O)[O-])O[C@@H]1O[C@H](C(=O)[O-])[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@H](COS(=O)(=O)[O-])[C@H]([C@@H]([C@H]1NS(=O)(=O)[O-])O)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Molecular Formula:
C31H43N3Na10O49S8
Molecular Weight:
1728.080
Log P:
-9.3412
Hydrogen Bond Acceptor:
52
Hydrogen Bond Donor:
9
TPSA:
900.82
CAS Number(s):
114870-03-0
Synonym(s)
1.
Fondaparinux
2.
Arixtra
3.
Fondaparinux Sodium
4.
Quixidar
External Link(s)
MeSHD000077425
PubChem Compound145925646
636380
CHEMBLCHEMBL1200644
KEGGdr:D01844
Therapeutic Target DatabaseD0NE9T
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Pulmonary EmbolismFAERS: 163US FAERS
2Drug ineffectiveFAERS: 100OFFSIDES
US FAERS
3ThrombosisFAERS: 84US FAERS
4Deep Vein ThrombosisFAERS: 83
Canada Vigilance: 1
Canada Vigilance
US FAERS
5Incorrect drug administration durationFAERS: 46OFFSIDES
US FAERS
6ThrombocytopeniaFAERS: 42US FAERS
7Product quality issueFAERS: 41OFFSIDES
US FAERS
8NauseaFAERS: 36US FAERS
9OverdoseFAERS: 34OFFSIDES
US FAERS
10MalaiseFAERS: 28US FAERS
11Heparin-induced thrombocytopeniaFAERS: 27
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
12PainFAERS: 27US FAERS
13Abdominal PainFAERS: 25US FAERS
14Cerebrovascular accidentFAERS: 23US FAERS
15HeadacheFAERS: 23US FAERS
16VomitingFAERS: 23US FAERS
17Adverse eventFAERS: 22US FAERS
18Drug exposure during pregnancyFAERS: 19OFFSIDES
US FAERS
19Injection site painFAERS: 19US FAERS
20Drug administration errorFAERS: 18US FAERS
21EpistaxisFAERS: 18OFFSIDES
US FAERS
22ShockFAERS: 18US FAERS
23UrticariaFAERS: 18US FAERS
24HypersensitivityFAERS: 16US FAERS
25HypotensionFAERS: 16US FAERS
26SwellingFAERS: 16US FAERS
27Depressed Level of ConsciousnessFAERS: 14US FAERS
28Skin necrosisFAERS: 14OFFSIDES
US FAERS
29Weight decreasedFAERS: 14US FAERS
30Chest PainFAERS: 13US FAERS
31FatigueFAERS: 13US FAERS
32PneumoniaFAERS: 13US FAERS
33ArthralgiaFAERS: 12US FAERS
34Incorrect dose administeredFAERS: 12OFFSIDES
US FAERS
35Intentional drug misuseFAERS: 12OFFSIDES
US FAERS
36Product physical issueFAERS: 12US FAERS
37Alanine Aminotransferase IncreasedFAERS: 11US FAERS
38AstheniaFAERS: 11US FAERS
39Cerebral InfarctionFAERS: 11US FAERS
40Disseminated Intravascular CoagulationFAERS: 11US FAERS
41General physical health deteriorationFAERS: 11OFFSIDES
US FAERS
42InfectionFAERS: 11US FAERS
43Pancreatic carcinomaFAERS: 11US FAERS
44PruritusFAERS: 11US FAERS
45AngioedemaFAERS: 10OFFSIDES
US FAERS
46AphasiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
47Post procedural complicationFAERS: 10OFFSIDES
US FAERS
48Prothrombin level decreasedFAERS: 10OFFSIDES
US FAERS
49SepsisFAERS: 10US FAERS
50Aspartate Aminotransferase IncreasedFAERS: 9US FAERS
51Blood creatinine increasedFAERS: 9US FAERS
52Disease ProgressionFAERS: 9US FAERS
53DizzinessFAERS: 9US FAERS
54Injection site bruisingFAERS: 9US FAERS
55PallorFAERS: 9OFFSIDES
US FAERS
56PhlebitisFAERS: 9OFFSIDES
US FAERS
57Respiratory FailureFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
58SomnolenceFAERS: 9US FAERS
59Back PainFAERS: 8US FAERS
60Blood alkaline phosphatase increasedFAERS: 8US FAERS
61Joint swellingFAERS: 8US FAERS
62Medication ErrorFAERS: 8US FAERS
63MydriasisFAERS: 8US FAERS
64No adverse eventFAERS: 8US FAERS
65TachycardiaFAERS: 8US FAERS
66Accidental overdoseFAERS: 7OFFSIDES
US FAERS
67Altered state of consciousnessFAERS: 7OFFSIDES
US FAERS
68Depressed moodFAERS: 7US FAERS
69Drug dose omissionFAERS: 7US FAERS
70Gamma-Glutamyltransferase IncreasedFAERS: 7US FAERS
71Gastric ulcerFAERS: 7OFFSIDES
US FAERS
72Injection site urticariaFAERS: 7OFFSIDES
US FAERS
73Injury associated with deviceFAERS: 7US FAERS
74Myocardial InfarctionFAERS: 7US FAERS
75Pharmaceutical product complaintFAERS: 7US FAERS
76Septic ShockFAERS: 7US FAERS
77Transaminases increasedFAERS: 7OFFSIDES
US FAERS
78Atrial FibrillationFAERS: 6US FAERS
79Cardiac ArrestFAERS: 6US FAERS
80ErythemaFAERS: 6US FAERS
81HemiparesisFAERS: 6OFFSIDES
US FAERS
82HemiplegiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
83InflammationFAERS: 6US FAERS
84Joint Range of Motion DecreasedFAERS: 6OFFSIDES
US FAERS
85MonoplegiaFAERS: 6OFFSIDES
US FAERS
86NecrosisFAERS: 6US FAERS
87NeutropeniaFAERS: 6US FAERS
88Postoperative wound complicationFAERS: 6OFFSIDES
US FAERS
89ThrombocytosisFAERS: 6US FAERS
90effusionFAERS: 6US FAERS
91Accidental needle stickFAERS: 5OFFSIDES
US FAERS
92AnorexiaFAERS: 5US FAERS
93Blood lactate dehydrogenase increasedFAERS: 5US FAERS
94DisorientationFAERS: 5US FAERS
95EcchymosisFAERS: 5US FAERS
96EmbolismFAERS: 5OFFSIDES
US FAERS
97Feeling abnormalFAERS: 5US FAERS
98IleusFAERS: 5US FAERS
99Incorrect route of drug administrationFAERS: 5OFFSIDES
US FAERS
100InfarctionFAERS: 5US FAERS
101Malignant neoplasm progressionFAERS: 5US FAERS
102Pulmonary thrombosisFAERS: 5OFFSIDES
US FAERS
103PurpuraFAERS: 5US FAERS
104SyncopeFAERS: 5US FAERS
105UlcerFAERS: 5US FAERS
106jaundiceFAERS: 5US FAERS
107Anaphylactic shockFAERS: 4US FAERS
108Angina PectorisFAERS: 4US FAERS
109Blood blisterFAERS: 4OFFSIDES
US FAERS
110ChemotherapyFAERS: 4US FAERS
111Chest discomfortFAERS: 4US FAERS
112Creatinine renal clearance decreasedFAERS: 4US FAERS
113Duodenal UlcerFAERS: 4OFFSIDES
US FAERS
114Emergency care examinationFAERS: 4US FAERS
115Fibrin D dimer increasedFAERS: 4US FAERS
116Hospice CareFAERS: 4US FAERS
117Injection site erythemaFAERS: 4OFFSIDES
US FAERS
118Joint stiffnessFAERS: 4US FAERS
119LethargyFAERS: 4US FAERS
120MetrorrhagiaFAERS: 4US FAERS
121MonoparesisFAERS: 4OFFSIDES
US FAERS
122PancytopeniaFAERS: 4US FAERS
123Post procedural pulmonary embolismFAERS: 4US FAERS
124Product substitution issueFAERS: 4US FAERS
125Respiratory distressFAERS: 4US FAERS
126Stevens-Johnson SyndromeFAERS: 4US FAERS
127SuperinfectionFAERS: 4US FAERS
128Therapeutic response unexpectedFAERS: 4US FAERS
129Urinary tract infectionFAERS: 4US FAERS
130VasculitisFAERS: 4US FAERS
131Venous thrombosis limbFAERS: 4OFFSIDES
US FAERS
132AbscessFAERS: 3US FAERS
133Accidental exposureFAERS: 3US FAERS
134Acute myocardial infarctionFAERS: 3US FAERS
135Anticoagulation drug level above therapeuticFAERS: 3OFFSIDES
US FAERS
136AnxietyFAERS: 3US FAERS
137Blood iron decreasedFAERS: 3OFFSIDES
US FAERS
138Blood urea increasedFAERS: 3US FAERS
139BradycardiaFAERS: 3US FAERS
140Cold sweatFAERS: 3US FAERS
141CyanosisFAERS: 3US FAERS
142Disease complicationFAERS: 3US FAERS
143Drug level increasedFAERS: 3US FAERS
144Drug prescribing errorFAERS: 3US FAERS
145DysarthriaFAERS: 3US FAERS
146DysgeusiaFAERS: 3US FAERS
147EczemaFAERS: 3US FAERS
148GastritisFAERS: 3US FAERS
149HypoxiaFAERS: 3OFFSIDES
US FAERS
150Impaired work abilityFAERS: 3US FAERS
151Inappropriate schedule of drug administrationFAERS: 3US FAERS
152Injection Site ReactionFAERS: 3US FAERS
153Injection site warmthFAERS: 3OFFSIDES
US FAERS
154LeukocytosisFAERS: 3US FAERS
155MenorrhagiaFAERS: 3US FAERS
156ParaplegiaFAERS: 3OFFSIDES
US FAERS
157PetechiaeFAERS: 3US FAERS
158Post procedural infectionFAERS: 3OFFSIDES
US FAERS
159Product storage errorFAERS: 3US FAERS
160Respiratory arrestFAERS: 3US FAERS
161Skin UlcerFAERS: 3US FAERS
162Sudden deathFAERS: 3US FAERS
163ThrombophlebitisFAERS: 3OFFSIDES
US FAERS
164Thrombosis in deviceFAERS: 3US FAERS
165Unevaluable eventFAERS: 3US FAERS
166Urinary IncontinenceFAERS: 3US FAERS
167Venous ThrombosisFAERS: 3US FAERS
168Visual ImpairmentFAERS: 3US FAERS
169Visual disturbanceFAERS: 3US FAERS
170Wound dehiscenceFAERS: 3OFFSIDES
US FAERS
171nervous system disorderFAERS: 3US FAERS
172AbasiaFAERS: 2US FAERS
173Abdominal symptomFAERS: 2OFFSIDES
US FAERS
174AdactylyFAERS: 2US FAERS
175AgitationFAERS: 2US FAERS
176AmnesiaFAERS: 2US FAERS
177Anaphylactoid ReactionFAERS: 2US FAERS
178AnuriaFAERS: 2OFFSIDES
US FAERS
179Apparent deathFAERS: 2US FAERS
180AtelectasisFAERS: 2US FAERS
181BedriddenFAERS: 2US FAERS
182BlindnessFAERS: 2US FAERS
183Blood albumin decreasedFAERS: 2US FAERS
184Blood creatine phosphokinase increasedFAERS: 2US FAERS
185Blood creatinine decreasedFAERS: 2US FAERS
186Blood fibrinogen abnormalFAERS: 2OFFSIDES
US FAERS
187Blood potassium increasedFAERS: 2US FAERS
188Blood pressure immeasurableFAERS: 2US FAERS
189Blood sodium decreasedFAERS: 2US FAERS
190Brain DeathFAERS: 2OFFSIDES
US FAERS
191BronchospasmFAERS: 2US FAERS
192Burning sensationFAERS: 2US FAERS
193Catheter related complicationFAERS: 2OFFSIDES
US FAERS
194Catheter site dischargeFAERS: 2OFFSIDES
US FAERS
195CellulitisFAERS: 2US FAERS
196ChromaturiaFAERS: 2OFFSIDES
US FAERS
197ConstipationFAERS: 2US FAERS
198CraniotomyFAERS: 2US FAERS
199DehydrationFAERS: 2US FAERS
200DeliriumFAERS: 2US FAERS
201Drug dispensing errorFAERS: 2US FAERS
202Drug level decreasedFAERS: 2US FAERS
203Drug specific antibody presentFAERS: 2OFFSIDES
US FAERS
204Duodenal perforationFAERS: 2OFFSIDES
US FAERS
205EosinophiliaFAERS: 2US FAERS
206Expired drug administeredFAERS: 2US FAERS
207Gaze palsyFAERS: 2US FAERS
208GingivitisFAERS: 2US FAERS
209Heparin resistanceFAERS: 2US FAERS
210Heparin-induced thrombocytopenia testFAERS: 2US FAERS
211HepatitisFAERS: 2US FAERS
212Hypocoagulable stateFAERS: 2OFFSIDES
US FAERS
213IndurationFAERS: 2OFFSIDES
US FAERS
214InfluenzaFAERS: 2US FAERS
215Injection site necrosisFAERS: 2US FAERS
216Intestinal ObstructionFAERS: 2US FAERS
217Iron deficiencyFAERS: 2US FAERS
218Leukocytoclastic vasculitisFAERS: 2US FAERS
219LeukopeniaFAERS: 2US FAERS
220Live BirthFAERS: 2OFFSIDES
US FAERS
221LymphadenopathyFAERS: 2US FAERS
222MalnutritionFAERS: 2US FAERS
223MeningorrhagiaFAERS: 2OFFSIDES
US FAERS
224Metabolic acidosisFAERS: 2US FAERS
225MyalgiaFAERS: 2US FAERS
226Neutrophil count decreasedFAERS: 2US FAERS
227Night sweatsFAERS: 2US FAERS
228Oral painFAERS: 2US FAERS
229Pelvic abscessFAERS: 2US FAERS
230Pericardial effusionFAERS: 2US FAERS
231PhotophobiaFAERS: 2US FAERS
232Platelet count abnormalFAERS: 2OFFSIDES
US FAERS
233PneumothoraxFAERS: 2US FAERS
234Post procedural dischargeFAERS: 2OFFSIDES
US FAERS
235Post procedural swellingFAERS: 2OFFSIDES
US FAERS
236Postoperative thrombosisFAERS: 2US FAERS
237Procedural complicationFAERS: 2US FAERS
238Protein total decreasedFAERS: 2OFFSIDES
US FAERS
239Pulmonary congestionFAERS: 2US FAERS
240Rehabilitation therapyFAERS: 2US FAERS
241Respiratory tract congestionFAERS: 2US FAERS
242RestlessnessFAERS: 2US FAERS
243RhabdomyolysisFAERS: 2US FAERS
244ScabFAERS: 2US FAERS
245Supraventricular tachycardiaFAERS: 2US FAERS
246Suture ruptureFAERS: 2OFFSIDES
US FAERS
247SyndactylyFAERS: 2US FAERS
248TalipesFAERS: 2US FAERS
249Throat irritationFAERS: 2US FAERS
250Unresponsive to stimuliFAERS: 2US FAERS
251Ventricular FibrillationFAERS: 2US FAERS
252White blood cell count decreasedFAERS: 2US FAERS
253Wound InfectionFAERS: 2OFFSIDES
US FAERS
254treatment failureFAERS: 2US FAERS
255Abdominal AbscessFAERS: 1US FAERS
256Abnormal clotting factorFAERS: 1US FAERS
257Accidental drug intake by childFAERS: 1US FAERS
258Accidental exposure to productFAERS: 1US FAERS
259AcneFAERS: 1US FAERS
260Activated partial thromboplastin time shortenedFAERS: 1OFFSIDES
US FAERS
261Activities of daily living impairedFAERS: 1US FAERS
262Acute Coronary SyndromeFAERS: 1OFFSIDES
US FAERS
263AmaurosisFAERS: 1US FAERS
264Anastomotic complicationFAERS: 1US FAERS
265AnosmiaFAERS: 1US FAERS
266Anti factor X antibody positiveFAERS: 1US FAERS
267Anticoagulant therapyFAERS: 1US FAERS
268Anticoagulation drug level below therapeuticFAERS: 1OFFSIDES
US FAERS
269Antiphospholipid SyndromeFAERS: 1OFFSIDES
US FAERS
270Apallic syndromeFAERS: 1US FAERS
271AphoniaFAERS: 1US FAERS
272Application site discomfortFAERS: 1US FAERS
273Application site painFAERS: 1US FAERS
274Arterial thrombosisFAERS: 1OFFSIDES
US FAERS
275Arteriovenous fistula thrombosisFAERS: 1US FAERS
276AscitesFAERS: 1US FAERS
277AsterixisFAERS: 1US FAERS
278Atrial tachycardiaFAERS: 1US FAERS
279Atrial thrombosisFAERS: 1US FAERS
280Auricular swellingFAERS: 1OFFSIDES
US FAERS
281Autoimmune thrombocytopeniaFAERS: 1US FAERS
282Bilirubin conjugated increasedFAERS: 1US FAERS
283Birth markFAERS: 1US FAERS
284Blood amylase increasedFAERS: 1US FAERS
285Blood creatine decreasedFAERS: 1US FAERS
286Blood fibrinogen increasedFAERS: 1OFFSIDES
US FAERS
287Blood glucose decreasedFAERS: 1US FAERS
288Blood immunoglobulin E increasedFAERS: 1US FAERS
289Blood sodium abnormalFAERS: 1OFFSIDES
US FAERS
290Bone painFAERS: 1US FAERS
291Brain ContusionFAERS: 1US FAERS
292BronchopneumoniaFAERS: 1US FAERS
293BronchoscopyFAERS: 1US FAERS
294Bullous lung diseaseFAERS: 1OFFSIDES
US FAERS
295Cardiac TamponadeFAERS: 1US FAERS
296Cardiac function test abnormalFAERS: 1US FAERS
297Carotid artery occlusionFAERS: 1US FAERS
298ChillsFAERS: 1US FAERS
299Choking sensationFAERS: 1US FAERS
300CholecystitisFAERS: 1US FAERS
301Coagulation factor X level abnormalFAERS: 1US FAERS
302Coagulation factor X level increasedFAERS: 1OFFSIDES
US FAERS
303Coagulation time shortenedFAERS: 1US FAERS
304Completed SuicideFAERS: 1US FAERS
305Creatinine renal clearance increasedFAERS: 1US FAERS
306CryingFAERS: 1US FAERS
307DebridementFAERS: 1US FAERS
308DermatitisFAERS: 1US FAERS
309Device deployment issueFAERS: 1US FAERS
310Device related infectionFAERS: 1US FAERS
311Diet refusalFAERS: 1US FAERS
312DiplopiaFAERS: 1US FAERS
313DisabilityFAERS: 1US FAERS
314Drug administered at inappropriate siteFAERS: 1US FAERS
315Drug administered to patient of inappropriate ageFAERS: 1US FAERS
316Drug clearance decreasedFAERS: 1US FAERS
317Drug exposure via breast milkFAERS: 1OFFSIDES
US FAERS
318Drug level above therapeuticFAERS: 1US FAERS
319Drug level below therapeuticFAERS: 1US FAERS
320Drug toxicityFAERS: 1US FAERS
321DuodenitisFAERS: 1US FAERS
322DysmorphismFAERS: 1US FAERS
323DyspepsiaFAERS: 1OFFSIDES
US FAERS
324DysphoniaFAERS: 1US FAERS
325Early menarcheFAERS: 1US FAERS
326Electromechanical dissociationFAERS: 1US FAERS
327EnteritisFAERS: 1US FAERS
328EosinopeniaFAERS: 1US FAERS
329ErysipelasFAERS: 1US FAERS
330Erythema MultiformeFAERS: 1US FAERS
331Escherichia infectionFAERS: 1US FAERS
332ExcoriationFAERS: 1OFFSIDES
US FAERS
333Exposure during breast feedingFAERS: 1US FAERS
334Failure to ThriveFAERS: 1US FAERS
335Failure to anastomoseFAERS: 1OFFSIDES
US FAERS
336False positive investigation resultFAERS: 1US FAERS
337Feeding disorder neonatalFAERS: 1US FAERS
338Feeling ColdFAERS: 1US FAERS
339Flat affectFAERS: 1US FAERS
340FlatulenceFAERS: 1US FAERS
341Foreign body traumaFAERS: 1US FAERS
342Gastrointestinal carcinomaFAERS: 1US FAERS
343GastroschisisFAERS: 1US FAERS
344Genital rashFAERS: 1US FAERS
345GoutFAERS: 1US FAERS
346Heparin-induced thrombocytopenia test positiveFAERS: 1US FAERS
347HepatosplenomegalyFAERS: 1US FAERS
348Hip surgeryFAERS: 1US FAERS
349HydrocephalusFAERS: 1US FAERS
350HypocapniaFAERS: 1US FAERS
351HypophagiaFAERS: 1US FAERS
352HypoventilationFAERS: 1US FAERS
353Iatrogenic injuryFAERS: 1US FAERS
354ImmobileFAERS: 1US FAERS
355Impaired self-careFAERS: 1US FAERS
356Inappropriate affectFAERS: 1US FAERS
357IncoherentFAERS: 1US FAERS
358Incorrect route of product administrationFAERS: 1US FAERS
359Incorrect storage of drugFAERS: 1US FAERS
360Increased bronchial secretionFAERS: 1US FAERS
361Increased tendency to bruiseFAERS: 1US FAERS
362Increased viscosity of bronchial secretionFAERS: 1US FAERS
363Infusion Site ExtravasationFAERS: 1US FAERS
364Injection site discomfortFAERS: 1US FAERS
365Injection site inflammationFAERS: 1US FAERS
366Injection site irritationFAERS: 1OFFSIDES
US FAERS
367Injection site massFAERS: 1US FAERS
368Injection site noduleFAERS: 1US FAERS
369Injection site pruritusFAERS: 1OFFSIDES
US FAERS
370Injection site ulcerFAERS: 1US FAERS
371Injection site vesiclesFAERS: 1OFFSIDES
US FAERS
372Intercepted drug dispensing errorFAERS: 1US FAERS
373Intestinal PerforationFAERS: 1US FAERS
374Intra-aortic balloon placementFAERS: 1US FAERS
375Intubation complicationFAERS: 1US FAERS
376Lip swellingFAERS: 1US FAERS
377LipoinjectionFAERS: 1US FAERS
378Living in residential institutionFAERS: 1US FAERS
379Low birth weight babyFAERS: 1US FAERS
380Macular degenerationFAERS: 1US FAERS
381Mechanical ventilationFAERS: 1OFFSIDES
US FAERS
382Medical device complicationFAERS: 1OFFSIDES
US FAERS
383Medical device removalFAERS: 1US FAERS
384Mental impairmentFAERS: 1US FAERS
385Metastatic NeoplasmFAERS: 1US FAERS
386Metastatic uterine cancerFAERS: 1US FAERS
387Multi-organ disorderFAERS: 1US FAERS
388Multiple SclerosisFAERS: 1US FAERS
389Muscle necrosisFAERS: 1OFFSIDES
US FAERS
390Musculoskeletal discomfortFAERS: 1US FAERS
391NasopharyngitisFAERS: 1US FAERS
392Needle issueFAERS: 1US FAERS
393Nephrotic SyndromeFAERS: 1US FAERS
394NervousnessFAERS: 1US FAERS
395Neurological decompensationFAERS: 1US FAERS
396Nipple painFAERS: 1US FAERS
397No adverse reactionFAERS: 1US FAERS
398Occult blood positiveFAERS: 1US FAERS
399Optic NeuritisFAERS: 1US FAERS
400OsteoporosisFAERS: 1US FAERS
401PROTHROMBIN TIMEFAERS: 1US FAERS
402PalpitationsFAERS: 1US FAERS
403PancreatitisFAERS: 1US FAERS
404ParesisFAERS: 1US FAERS
405Percutaneous Coronary InterventionFAERS: 1US FAERS
406Perforated ulcerFAERS: 1US FAERS
407Peripheral swellingFAERS: 1US FAERS
408PhotodermatosisFAERS: 1US FAERS
409Platelet adhesiveness increasedFAERS: 1US FAERS
410Postoperative heterotopic calcificationFAERS: 1US FAERS
411Pre-EclampsiaFAERS: 1US FAERS
412Procedural hypotensionFAERS: 1US FAERS
413Product package associated injuryFAERS: 1US FAERS
414Product packaging issueFAERS: 1US FAERS
415Product packaging quantity issueFAERS: 1US FAERS
416Product use issueFAERS: 1US FAERS
417Pulmonary HypertensionFAERS: 1US FAERS
418Quality of life decreasedFAERS: 1US FAERS
419Rash erythematousFAERS: 1US FAERS
420Renal Cell CarcinomaFAERS: 1US FAERS
421Renal ColicFAERS: 1US FAERS
422Renal vasculitisFAERS: 1US FAERS
423RetchingFAERS: 1US FAERS
424Sciatic Nerve PalsyFAERS: 1OFFSIDES
US FAERS
425SclerodermaFAERS: 1US FAERS
426Septic embolusFAERS: 1US FAERS
427Sinus TachycardiaFAERS: 1US FAERS
428Skin irritationFAERS: 1US FAERS
429Skin lacerationFAERS: 1US FAERS
430Skin lesionFAERS: 1US FAERS
431Skin noduleFAERS: 1US FAERS
432Small cell lung cancer metastaticFAERS: 1US FAERS
433Splenic RuptureFAERS: 1US FAERS
434Staphylococcal abscessFAERS: 1US FAERS
435Stent-graft malfunctionFAERS: 1US FAERS
436StomatitisFAERS: 1US FAERS
437StressFAERS: 1US FAERS
438Superior Mesenteric Artery SyndromeFAERS: 1US FAERS
439Suspected counterfeit productFAERS: 1US FAERS
440Synovial CystFAERS: 1OFFSIDES
US FAERS
441Syringe issueFAERS: 1US FAERS
442TensionFAERS: 1US FAERS
443ThirstFAERS: 1US FAERS
444Thrombotic strokeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
445TinnitusFAERS: 1US FAERS
446TroponinFAERS: 1US FAERS
447Urinary RetentionFAERS: 1US FAERS
448Uterine spasmFAERS: 1US FAERS
449Vena cava filter insertionFAERS: 1OFFSIDES
US FAERS
450Venogram abnormalFAERS: 1US FAERS
451Venogram normalFAERS: 1US FAERS
452VertigoFAERS: 1US FAERS
453Vessel perforationFAERS: 1US FAERS
454Vocal Cord ParalysisFAERS: 1OFFSIDES
US FAERS
455Walking aid userFAERS: 1US FAERS
456Wound decompositionFAERS: 1US FAERS
457Wound eviscerationFAERS: 1US FAERS
458Wound necrosisFAERS: 1US FAERS
459Wrong drug administeredFAERS: 1US FAERS
460Wrong technique in drug usage processFAERS: 1US FAERS
461Wrong technique in product usage processFAERS: 1US FAERS
462colonoscopyFAERS: 1US FAERS
463Abdominal Compartment SyndromeOFFSIDES
464AgraphiaOFFSIDES
465AkinesiaOFFSIDES
466AlveolitisOFFSIDES
467AmyloidosisOFFSIDES
468Anticholinergic SyndromeOFFSIDES
469Application site noduleOFFSIDES
470Asymptomatic bacteriuriaOFFSIDES
471Autonomic neuropathyOFFSIDES
472Bacterial sepsisOFFSIDES
473Bladder tamponadeOFFSIDES
474Blood electrolytes decreasedOFFSIDES
475Blood iron increasedOFFSIDES
476Body TemperatureOFFSIDES
477Bone density increasedOFFSIDES
478Bowel movement irregularityOFFSIDES
479Breast cancer recurrentOFFSIDES
480BronchiectasisOFFSIDES
481Bronchoalveolar lavage abnormalOFFSIDES
482BursitisOFFSIDES
483CalciphylaxisOFFSIDES
484Cardioactive drug levelOFFSIDES
485Catheter placementOFFSIDES
486Cauda Equina SyndromeOFFSIDES
487Cell DeathOFFSIDES
488Cerebellar AtaxiaOFFSIDES
489ChondromalaciaOFFSIDES
490ChondroplastyOFFSIDES
491Chronic respiratory failureOFFSIDES
492Clostridium difficile toxin test positiveOFFSIDES
493DermatomyositisOFFSIDES
494Diabetic NephropathyOFFSIDES
495Diabetic RetinopathyOFFSIDES
496DiverticulumOFFSIDES
497Early satietyOFFSIDES
498EncephalomalaciaOFFSIDES
499Erythema InduratumOFFSIDES
500Eye InfectionOFFSIDES
501Facial NeuralgiaOFFSIDES
502Fibrin increasedOFFSIDES
503Gastrointestinal inflammationOFFSIDES
504Gastrointestinal obstructionOFFSIDES
505Gastrointestinal ulcerOFFSIDES
506General physical conditionOFFSIDES
507Genital HerpesOFFSIDES
508Glasgow coma scaleOFFSIDES
509GliosisOFFSIDES
510GlossitisOFFSIDES
511Graft infectionOFFSIDES
512Head deformityOFFSIDES
513Heat ExhaustionOFFSIDES
514HemothoraxOFFSIDES
515HepatotoxicityOFFSIDES
516Hilar lymphadenopathyOFFSIDES
517Hip swellingOFFSIDES
518HypogeusiaOFFSIDES
519HypomaniaOFFSIDES
520HyporeflexiaOFFSIDES
521Implantable defibrillator malfunctionOFFSIDES
522Infective tenosynovitisOFFSIDES
523Infusion site mobility decreasedOFFSIDES
524Joint prosthesis userOFFSIDES
525Kidney FailureOFFSIDES
526Klebsiella sepsisOFFSIDES
527LegionellaOFFSIDES
528Lower respiratory tract infection viralOFFSIDES
529Lymphocyte count decreasedOFFSIDES
530Lymphocyte percentage decreasedOFFSIDES
531MediastinitisOFFSIDES
532Medical device discomfortOFFSIDES
533MeningiomaOFFSIDES
534Meniscus removalOFFSIDES
535Mixed hepatocellular-cholestatic injuryOFFSIDES
536Mixed liver injuryOFFSIDES
537MononeuritisOFFSIDES
538Myasthenia GravisOFFSIDES
539Nerve Root CompressionOFFSIDES
540NeuralgiaOFFSIDES
541Non-cardiac chest painOFFSIDES
542ObstructionOFFSIDES
543Ocular icterusOFFSIDES
544Oculomucocutaneous syndromeOFFSIDES
545Open reduction of fractureOFFSIDES
546Oral polypectomyOFFSIDES
547Orthosis userOFFSIDES
548Paraneoplastic dermatomyositisOFFSIDES
549Pelvic fluid collectionOFFSIDES
550Peripheral arterial occlusive diseaseOFFSIDES
551Poor feeding infantCanada Vigilance: 1Canada Vigilance
552Portal Vein ThrombosisOFFSIDES
553Postinfarction anginaOFFSIDES
554Postoperative abscessOFFSIDES
555Postoperative ileusOFFSIDES
556Postoperative infectionOFFSIDES
557Procedural site reactionOFFSIDES
558Product dose omissionCanada Vigilance: 1Canada Vigilance
559ProlactinomaOFFSIDES
560Prothrombin level abnormalOFFSIDES
561Prothrombin time ratio increasedOFFSIDES
562Pseudomonal sepsisOFFSIDES
563Psychiatric symptomOFFSIDES
564Pulmonary InfarctionOFFSIDES
565Pulmonary arterial hypertensionOFFSIDES
566RalesOFFSIDES
567Renal scan abnormalOFFSIDES
568Renal tubular necrosisOFFSIDES
569Retroperitoneal fibrosisOFFSIDES
570Retroperitoneal lymphadenopathyOFFSIDES
571Sense of oppressionOFFSIDES
572SequestrectomyOFFSIDES
573Shoulder deformityOFFSIDES
574Sinus headacheOFFSIDES
575Skin graft failureOFFSIDES
576Thoracic Outlet SyndromeOFFSIDES
577Toe operationOFFSIDES
578Tracheal fistulaOFFSIDES
579Transaminases decreasedOFFSIDES
580Transfusion ReactionOFFSIDES
581Traumatic liver injuryOFFSIDES
582Troponin increasedOFFSIDES
583Umbilical cord vascular disorderOFFSIDES
584Urethral StenosisOFFSIDES
585VIIth nerve paralysisOFFSIDES
586Wound ComplicationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.